QSI Stock Risk & Deep Value Analysis
Quantum-Si Inc
Healthcare • Medical Devices
DVR Score
out of 10
What You Need to Know About QSI Stock
We analyzed Quantum-Si Inc using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran QSI through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Aggressive investment. Here's what we found.
How Risky Is QSI Stock?
Overall Risk
Aggressive investment
Financial Risk
High
Market Risk
Medium
Competitive Risk
High
Execution Risk
High
Regulatory Risk
Low
What Are the Red Flags for QSI?
- ⚠
Higher-than-expected cash burn in upcoming quarters, accelerating need for capital
- ⚠
Slower-than-anticipated instrument adoption or utilization rates by research institutions
- ⚠
Failure to secure additional funding without significant shareholder dilution
- ⚠
Competitive advancements from established players or new entrants in the proteomics space
Unlock QSI Red Flags & Risk Warnings
Create a free account to see the full analysis
What Does Quantum-Si Inc (QSI) Do?
Market Cap
$361.25M
Sector
Healthcare
Industry
Medical Devices
Employees
149
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company offers Platinum NGPS instrument that provides single molecule amino acid level resolution with a streamlined workflow, including automated data analysis that accessible to researchers in all laboratory types; Platinum Pro NGPS instrument, a single molecule amino acid resolution, which provides an enhanced user interface, cloud or on instrument data analysis and an available pro mode; Library preparation kits to prepare protein sample for sequencing; Barcoding Kits to optimize the workflow and performance of technology; and Sequencing Kits contains the reagents and consumables used to perform NGPS on the Platinum or Platinum Pro instrument. It also provides Platinum Analysis Software, a cloud-based solution that automates data analysis workflows and provides a user-friendly interface and visualization of the sequencing results. Its products are used in antibody characterization, biomarker identification, protein identification, protein variants, protein barcoding, and post translational modification analysis applications. Quantum-Si incorporated was founded in 2013 is headquartered in Branford, Connecticut.
Visit Quantum-Si Inc WebsiteIs QSI Stock Undervalued?
Unlock the full AI analysis for QSI
Get the complete DVR score, risk analysis, and more
Does QSI Have a Competitive Moat?
Sign in to unlockMoat Rating
🛡️ Narrow
Moat Trend
Expanding
Moat Sources
2 Identified
The moat is currently being built around its novel, potentially disruptive technology and associated patents. Its durability depends on rapid commercial adoption, continuous innovation to maintain a technological lead, and establishing itself as a standard for certain protein analysis workflows before competitors catch up with similar or superior offerings. An early lead in a new paradigm is critical.
Moat Erosion Risks
- •Emergence of superior, faster, or cheaper competing technologies that bypass QSI's approach
- •Failure to scale manufacturing or effectively protect its intellectual property globally
- •Lack of widespread clinical or research adoption due to unproven applications, performance, or cost barriers for potential customers
QSI Competitive Moat Analysis
Sign up to see competitive advantages
What Could Drive QSI Stock Higher?
Near-Term (0-6 months)
- •Q1 2026 Earnings Report (Estimated late April/early May 2026), focusing on instrument placements and cash burn
- •Updates on instrument placement numbers and utilization rates from Q1 reporting
- •Announcements of new strategic collaborations or key customer wins validating technology
Medium-Term (6-18 months)
- •Expansion of product pipeline or new application areas for the Platinum™ sequencing platform
- •Demonstration of significant cost reduction per protein sequence, broadening market appeal
- •Progress towards achieving positive gross margins on consumables as scale improves
Long-Term (18+ months)
- •Establishment as a market leader in digital proteomics sequencing, capturing significant market share
- •Disruption of traditional mass spectrometry for high-throughput, accessible protein analysis
- •Integration of AI/ML for advanced protein data analysis, enhancing platform value
Catalysts & Growth Drivers
Upgrade to Premium to see catalysts
What's the Bull Case for QSI?
- ✓
Acceleration in instrument placements and a significant increase in consumables revenue (indicating high utilization)
- ✓
Demonstrable improvements in gross margins and a clear path to reduced cash burn or cash flow positivity
- ✓
Positive customer testimonials and peer-reviewed validation studies demonstrating clinical/research utility and competitive advantage
- ✓
Successful capital raises at favorable terms, reducing dilution concerns
Bull Case Analysis
See what could go right with Premium
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for QSI (Quantum-Si Inc) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.
